<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu H</submitter><funding>Human Frontier Science Program</funding><funding>University of Melbourne</funding><funding>NHMRC</funding><funding>National Health and Medical Research Council</funding><funding>Australian Research Council</funding><pagination>1695-703</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4995085</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>213(9)</volume><pubmed_abstract>Major histocompatibility complex class II (MHC II) expression is tightly regulated, being subjected to cell type-specific mechanisms that closely control its levels at the cell surface. Ubiquitination by the E3 ubiquitin ligase MARCH 1 regulates MHC II expression in dendritic cells and B cells. In this study, we demonstrate that the related ligase MARCH 8 is responsible for regulating surface MHC II in thymic epithelial cells (TECs). March8(-/-) mice have elevated MHC II at the surface of cortical TECs and autoimmune regulator (AIRE)(-) medullary TECs (mTECs), but not AIRE(+) mTECs. Despite this, thymic and splenic CD4(+) T cell numbers and repertoires remained unaltered in March8(-/-) mice. Notably, the ubiquitination of MHC II by MARCH 8 is controlled by CD83. Mice expressing a mutated f</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.</pubmed_title><pmcid>PMC4995085</pmcid><funding_grant_id>1049724</funding_grant_id><funding_grant_id>1058193</funding_grant_id><funding_grant_id>DP110101383</funding_grant_id><funding_grant_id>1016629</funding_grant_id><funding_grant_id>1090236</funding_grant_id><funding_grant_id>RGP0064</funding_grant_id><funding_grant_id>1071916</funding_grant_id><funding_grant_id>1078763</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Jain R</pubmed_authors><pubmed_authors>Gray DH</pubmed_authors><pubmed_authors>Villadangos JA</pubmed_authors><pubmed_authors>Vuong V</pubmed_authors><pubmed_authors>Guan J</pubmed_authors><pubmed_authors>La Gruta NL</pubmed_authors><pubmed_authors>Mintern JD</pubmed_authors><pubmed_authors>Ishido S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.</name><description>Major histocompatibility complex class II (MHC II) expression is tightly regulated, being subjected to cell type-specific mechanisms that closely control its levels at the cell surface. Ubiquitination by the E3 ubiquitin ligase MARCH 1 regulates MHC II expression in dendritic cells and B cells. In this study, we demonstrate that the related ligase MARCH 8 is responsible for regulating surface MHC II in thymic epithelial cells (TECs). March8(-/-) mice have elevated MHC II at the surface of cortical TECs and autoimmune regulator (AIRE)(-) medullary TECs (mTECs), but not AIRE(+) mTECs. Despite this, thymic and splenic CD4(+) T cell numbers and repertoires remained unaltered in March8(-/-) mice. Notably, the ubiquitination of MHC II by MARCH 8 is controlled by CD83. Mice expressing a mutated f</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2025-04-25T22:39:36.891Z</modification><creation>2019-03-27T02:22:28Z</creation></dates><accession>S-EPMC4995085</accession><cross_references><pubmed>27503069</pubmed><doi>10.1084/jem.20160312</doi></cross_references></HashMap>